Study using biomarkers to learn about neurological diseases
Part of Brain & nervous system clinical trials.
This study looks at “biomarkers,” which are measurable signs in the body, to learn more about neurological diseases. If you join and can be followed over time, your information may help researchers understand disease patterns and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a neurological (brain or nervous system) disease
- You (or your legal representative) agree to participate and sign informed consent
- You are not currently taking part as an investigator in another clinical research study
- You’re willing and able to come back for follow-up visits
- You can follow the study plan and take part reliably as instructed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for “biomarkers” (measurable signs from blood and brain tests) that may help predict who with mild cognitive impairment (MCI) could later develop dementia. Results may help doctors spot risk earlier and better plan care.
This study is looking for people with neurodegenerative diseases (like Alzheimer's, Parkinson's, ALS) to help researchers find new markers in the body that could help understand these conditions better and possibly lead to better treatments.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
This study looks for “biomarkers” (measurable signs in blood or other samples) in people with motor neuron disease and frontotemporal dementia spectrum conditions. It also compares those findings with matched caregivers, to understand what might be happening in these diseases.
This study looks at how infections or inflammation involving the brain and spinal cord work, using patient data and samples. It may help researchers better understand these illnesses and improve future care.
This study tracks changes in people with Parkinson's disease, other movement disorders, or cognitive decline to find better ways to measure disease progression.
Hear when a new Biomarkers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.